ICU MEDICAL INC/DE (ICUI)

Import this data to Google Sheets with:

=jivedata("ICUI","financials")

Full statements spill as a table. For one cell: =jivedata("ICUI","Revenue") or =jivedata("ICUI","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

ICU MEDICAL INC/DE

ICUI • CIK 0000883984

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenues	$2,259,126	$2,382,046	$2,231,262	$2,159,602
Cost of Goods and Services Sold	$1,519,253	$1,557,264	$1,409,223	$1,409,223
Gross Profit	$739,873	$824,782	$822,039	$845,145
Operating Income (Loss)	$22,825	$42,964	$42,829	$72,060
Interest Income (Expense), Net	$-95,219	$-95,753	$-83,031	$-83,031
Nonoperating Income (Expense)	$-5,905	$-13,223	$-232	$-1,583
Gain (Loss) on Disposition of Business	—	—	$44,792	$2,969
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest	—	—	$4,358	$4,358
Income Tax Expense (Benefit)	$-48,644	$51,676	$2,437	$-30,955
Income (Loss) from Equity Method Investments	—	—	$-1,189	$-1,620
Net Income (Loss) Attributable to Parent	$-29,655	$-117,688	$732	$46,340
Selling, General and Administrative Expense	$606,693	$638,762	$625,210	$615,073
Research and Development Expense	$85,344	$88,615	$87,495	$86,319
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$-16,247	$-5,399	$0	$0
Operating Expenses	$717,048	$781,818	$779,210	$773,085
Weighted Average Number of Shares Outstanding, Basic	24,091,000	24,388,000	24,640,000	24,931,000
Weighted Average Number of Shares Outstanding, Diluted	24,091,000	24,388,000	24,904,000	25,290,000
Derivative, Gain (Loss) on Derivative, Net	—	—	$14,426	$14,426

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Property, Plant and Equipment, Net	$612,909	$442,746	$451,817	$446,798
Operating Lease, Right-of-Use Asset	$69,909	$53,295	$54,470	$38,610
Goodwill	$1,472,446	$1,432,772	$1,499,754	$1,484,384
Intangible Assets, Net (Excluding Goodwill)	$870,588	$740,789	$633,559	$567,665
Deferred Income Tax Assets, Net	$37,295	$24,211	$25,891	$25,569
Other Assets, Noncurrent	$94,020	$68,135	$62,877	$63,435
Equity Method Investments	$3,120	$3,038	$131,586	$133,913
Assets	$4,378,439	$4,203,931	$4,050,508	$3,971,282
Secured Long-term Debt, Noncurrent	$1,577,770	$1,531,858	$1,265,917	$1,265,917
Other Accrued Liabilities, Noncurrent	—	—	$89,536	$89,536
Deferred Income Tax Liabilities, Net	$55,873	$48,814	$37,756	$12,227
Accrued Income Taxes, Noncurrent	$35,060	$35,097	$34,613	$25,397
Commitments and Contingencies	$0	$0	$0	$0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$254,222	$308,566	$307,963	$298,299
Accounts Receivable, after Allowance for Credit Loss, Current	$161,566	$182,828	$180,515	$183,531
Inventory, Net	$709,360	$584,676	$615,859	$607,421
Prepaid Expense and Other Assets, Current	$73,640	$70,287	$86,217	$121,657
Disposal Group, Including Discontinued Operation, Assets	—	$284,382	$0	$5,294
Assets, Current	$1,221,272	$1,441,983	$1,190,554	$1,210,908
Accounts Payable, Current	$150,030	$148,020	$154,374	$149,165
Accrued Liabilities, Current	$268,215	$306,923	$315,337	$322,489
Long-term Debt, Current Maturities	$51,000	$51,000	$18,750	$18,750
Accrued Income Taxes, Current	$7,714	$17,328	$10,400	$7,960
Disposal Group, Including Discontinued Operation, Liabilities	—	$32,911	$0	$0
Liabilities, Current	$481,838	$556,182	$498,861	$498,364
Common Stock, Value, Issued	$2,414	$2,452	$2,469	$2,519
Additional Paid in Capital, Common Stock	$1,366,493	$1,412,118	$1,465,118	$1,475,974
Treasury Stock, Value	$262	$92	$22	$23,415
Retained Earnings (Accumulated Deficit)	$807,846	$690,158	$690,890	$740,109
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-53,081	$-139,401	$-34,630	$-43,336
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$2,123,410	$1,965,235	$2,123,825	$2,151,851
Accounts Receivable, Allowance for Credit Loss, Current	$11,064	$12,977	$14,383	$14,383
Preferred Stock, Shares Authorized	500,000	500,000	500,000	500,000
Preferred Stock, Shares Outstanding	0	0	0	0
Common Stock, Shares Authorized	80,000,000	80,000,000	80,000,000	80,000,000
Common Stock, Shares, Issued	24,144,000	24,518,000	24,688,000	25,186,000
Common Stock, Shares, Outstanding	24,141,000	24,517,000	24,688,000	25,007,000
Treasury Stock, Common, Shares	2,428	571	172	179,637
Operating Lease, Liability, Current	$20,161	$15,695	$13,825	$13,221
Operating Lease, Liability, Noncurrent	$52,972	$40,777	$43,951	$36,626
Operating Lease, Liability	$73,133	$56,472	$57,776	$49,847
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	$2,707	$3,259	$5,599	$5,853
Finance Lease, Liability, Current	$860	$1,066	$2,095	$2,357
Finance Lease, Liability, Noncurrent	$1,954	$2,332	$3,729	$3,744
Finance Lease, Liability	$2,814	$3,398	$5,824	$6,101
Derivative Liability	—	—	$5,250	$1,034
Derivative Asset, Current	$6,785	$6,716	$4,838	$9,119
Derivative Asset, Noncurrent	—	—	$734	$2,503
Derivative Liability, Current	—	—	$1,987	$1,017
Derivative Liability, Noncurrent	—	—	$3,263	$17

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Interest Paid, Excluding Capitalized Interest, Operating Activities	$95,913	$99,717	$83,742	$73,934
Capital Expenditures Incurred but Not yet Paid	$6,570	$7,443	$4,453	$-4,330
Transfer to Investments	—	—	$129,851	$4,025
Net Cash Provided by (Used in) Operating Activities	$166,201	$204,033	$179,847	$236,368
Net Cash Provided by (Used in) Investing Activities	$-87,947	$-88,960	$122,229	$-79,765
Net Cash Provided by (Used in) Financing Activities	$-35,979	$-55,800	$-311,525	$-154,531
Net Income (Loss) Attributable to Parent	$-29,655	$-117,688	$732	$46,340
Depreciation, Depletion and Amortization	$228,774	$219,512	$200,741	$201,271
Operating Lease, Right-of-Use Asset, Amortization Expense	$21,910	$21,344	$17,251	$16,079
Share-based Payment Arrangement, Noncash Expense	$40,563	$46,883	$55,758	$55,003
Gain (Loss) on Disposition of Property Plant Equipment	$-2,109	$-2,522	$-5,900	$-6,130
Amortization of Debt Issuance Costs	$6,814	$6,807	$6,178	$4,270
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$-16,247	$-5,399	$0	$0
Income (Loss) from Equity Method Investments	—	—	$-1,189	$-1,620
Gain (Loss) on Disposition of Business	—	—	$44,792	$2,969
Gain (Loss) on Extinguishment of Debt	—	—	$-2,463	$-2,463
Other Operating Activities, Cash Flow Statement	$8,049	$7,393	$24,471	$24,471
Increase (Decrease) in Accounts Receivable	$-48,635	$46,844	$-8,876	$15,377
Increase (Decrease) in Inventories	$6,079	$-16,829	$26,252	$-7,586
Increase (Decrease) in Prepaid Expense and Other Assets	$-11,672	$8,829	$10,958	$18,211
Increase (Decrease) in Other Operating Assets	$24,695	$23,154	$6,982	$4,236
Increase (Decrease) in Accounts Payable	$-68,301	$12,531	$6,998	$-12,293
Increase (Decrease) in Accrued Liabilities	$-14,479	$20,668	$-36,967	$-23,027
Payments to Acquire Property, Plant, and Equipment	$83,893	$79,373	$88,043	$83,539
Proceeds from Divestiture of Businesses	—	$200,000	$211,185	$211,185
Proceeds from Sale of Other Property, Plant, and Equipment	$1,501	$746	$8,059	$8,059
Payments to Acquire Intangible Assets	$9,777	$10,833	$8,972	$7,986
Proceeds from Sale and Maturity of Marketable Securities	$4,222	$500	$0	$0
Payments of Debt Issuance Costs	$0	$0	$2,825	$2,825
Repayments of Long-term Debt	$29,688	$51,000	$302,750	$109,688
Proceeds from Stock Options Exercised	$4,022	$10,939	$6,106	$624
Finance Lease, Principal Payments	$963	$1,147	$2,048	$2,460
Payment for Contingent Consideration Liability, Financing Activities	$0	$2,600	$0	$0
Payments for Repurchase of Common Stock	$9,350	$11,992	$8,766	$8,766
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$3,163	$-4,929	$8,846	$-3,798
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$45,438	$54,344	$-603	$-1,726
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$254,222	$308,566	$307,963	$306,589

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("ICUI","financials")

Full statements spill as a table. For one cell: =jivedata("ICUI","Revenue") or =jivedata("ICUI","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.